5-Methyltetrahydrofolic acid (MFH4): an effective folate for the treatment of advanced colorectal cancer with 5-FU

Recent Results Cancer Res. 1988:110:219-25. doi: 10.1007/978-3-642-83293-2_34.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / mortality
  • Adult
  • Aged
  • Clinical Trials as Topic
  • Colonic Neoplasms / drug therapy*
  • Colonic Neoplasms / mortality
  • Drug Therapy, Combination
  • Female
  • Fluorouracil / administration & dosage*
  • Fluorouracil / adverse effects
  • Humans
  • Liver Neoplasms / drug therapy
  • Liver Neoplasms / secondary
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / secondary
  • Male
  • Middle Aged
  • Pelvic Neoplasms / drug therapy
  • Pelvic Neoplasms / secondary
  • Rectal Neoplasms / drug therapy*
  • Rectal Neoplasms / mortality
  • Tetrahydrofolates / administration & dosage*
  • Tetrahydrofolates / adverse effects

Substances

  • Tetrahydrofolates
  • 5-methyltetrahydrofolate
  • Fluorouracil